These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25589220)

  • 1. Effect of axitinib on the QT interval in healthy volunteers.
    Ruiz-Garcia A; Houk BE; Pithavala YK; Toh M; Sarapa N; Tortorici MA
    Cancer Chemother Pharmacol; 2015 Mar; 75(3):619-28. PubMed ID: 25589220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ketoconazole on the pharmacokinetics of axitinib in healthy volunteers.
    Pithavala YK; Tong W; Mount J; Rahavendran SV; Garrett M; Hee B; Selaru P; Sarapa N; Klamerus KJ
    Invest New Drugs; 2012 Feb; 30(1):273-81. PubMed ID: 20740300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, crossover, placebo- and moxifloxacin-controlled study to evaluate the effects of bosutinib (SKI-606), a dual Src/Abl tyrosine kinase inhibitor, on cardiac repolarization in healthy adult subjects.
    Abbas R; Hug BA; Leister C; Sonnichsen D
    Int J Cancer; 2012 Aug; 131(3):E304-11. PubMed ID: 22065400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
    Hulhoven R; Rosillon D; Bridson WE; Meeus MA; Salas E; Stockis A
    Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thorough QT study of the effects of vildagliptin, a dipeptidyl peptidase IV inhibitor, on cardiac repolarization and conduction in healthy volunteers.
    He YL; Zhang Y; Serra D; Wang Y; Ligueros-Saylan M; Dole WP
    Curr Med Res Opin; 2011 Jul; 27(7):1453-63. PubMed ID: 21609207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Renal Impairment on the Pharmacokinetics and Safety of Axitinib.
    Chen Y; Rini BI; Motzer RJ; Dutcher JP; Rixe O; Wilding G; Stadler WM; Tarazi J; Garrett M; Pithavala YK
    Target Oncol; 2016 Apr; 11(2):229-34. PubMed ID: 26400730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-administration of ketoconazole with H1-antagonists ebastine and loratadine in healthy subjects: pharmacokinetic and pharmacodynamic effects.
    Chaikin P; Gillen MS; Malik M; Pentikis H; Rhodes GR; Roberts DJ
    Br J Clin Pharmacol; 2005 Mar; 59(3):346-54. PubMed ID: 15752381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ritonavir 100 mg does not cause QTc prolongation in healthy subjects: a possible role as CYP3A inhibitor in thorough QTc studies.
    Sarapa N; Nickens DJ; Raber SR; Reynolds RR; Amantea MA
    Clin Pharmacol Ther; 2008 Jan; 83(1):153-9. PubMed ID: 17581594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of single-agent axitinib across multiple solid tumor types.
    Tortorici MA; Cohen EE; Pithavala YK; Garrett M; Ruiz-Garcia A; Kim S; Fruehauf JP
    Cancer Chemother Pharmacol; 2014 Dec; 74(6):1279-89. PubMed ID: 25336084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prokinetic cinitapride has no clinically relevant pharmacokinetic interaction and effect on QT during coadministration with ketoconazole.
    Robert M; Salvà M; Segarra R; Pavesi M; Esbri R; Roberts D; Golor G
    Drug Metab Dispos; 2007 Jul; 35(7):1149-56. PubMed ID: 17437965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effect of reboxetine on cardiac repolarization.
    Fleishaker JC; Francom SF; Herman BD; Knuth DW; Azie NE
    Clin Pharmacol Ther; 2001 Sep; 70(3):261-9. PubMed ID: 11557914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacology of axitinib.
    Chen Y; Tortorici MA; Garrett M; Hee B; Klamerus KJ; Pithavala YK
    Clin Pharmacokinet; 2013 Sep; 52(9):713-25. PubMed ID: 23677771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axitinib for the treatment of advanced renal cell carcinoma.
    Akaza H; Fukuyama T
    Expert Opin Pharmacother; 2014 Feb; 15(2):283-97. PubMed ID: 24328549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability of heart rate correction methods for the QT interval.
    Desai M; Li L; Desta Z; Malik M; Flockhart D
    Br J Clin Pharmacol; 2003 Jun; 55(6):511-7. PubMed ID: 12814443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single-dose placebo- and moxifloxacin-controlled study of the effects of temsirolimus on cardiac repolarization in healthy adults.
    Boni JP; Leister C; Hug B; Burns J; Sonnichsen D
    Cancer Chemother Pharmacol; 2012 Jun; 69(6):1433-42. PubMed ID: 22367193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the effects of bitopertin (RG1678) on cardiac repolarization: a thorough corrected QT study in healthy male volunteers.
    Hofmann C; Banken L; Hahn M; Swearingen D; Nagel S; Martin-Facklam M
    Clin Ther; 2012 Oct; 34(10):2061-71. PubMed ID: 22980315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QT effects of duloxetine at supratherapeutic doses: a placebo and positive controlled study.
    Zhang L; Chappell J; Gonzales CR; Small D; Knadler MP; Callaghan JT; Francis JL; Desaiah D; Leibowitz M; Ereshefsky L; Hoelscher D; Leese PT; Derby M
    J Cardiovasc Pharmacol; 2007 Mar; 49(3):146-53. PubMed ID: 17414226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of significant effect of bilastine administered at therapeutic and supratherapeutic doses and concomitantly with ketoconazole on ventricular repolarization: results of a thorough QT study (TQTS) with QT-concentration analysis.
    Tyl B; Kabbaj M; Azzam S; Sologuren A; Valiente R; Reinbolt E; Roupe K; Blanco N; Wheeler W
    J Clin Pharmacol; 2012 Jun; 52(6):893-903. PubMed ID: 21642470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone.
    Potkin SG; Preskorn S; Hochfeld M; Meng X
    J Clin Psychopharmacol; 2013 Feb; 33(1):3-10. PubMed ID: 23277250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lenvatinib (E7080) on the QTc interval: results from a thorough QT study in healthy volunteers.
    Shumaker RC; Zhou M; Ren M; Fan J; Martinez G; Aluri J; Darpo B
    Cancer Chemother Pharmacol; 2014 Jun; 73(6):1109-17. PubMed ID: 24658627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.